MacroPore Biosurgery, Inc. (Frankfurt:XMP), a company developing therapies for cardiovascular disease, spine and orthopedic disorders and reconstructive surgery using adult stem cells from adipose tissue, today announced financial results for the three and nine months ended September 30, 2004.